Anti-Inflamatory Drug for Myocardial Injury in Acute Coronary Syndrome
Acute coronary syndrome (ACS) as the acute setting of coronary chronic syndrome has been widely known to have high mortality rates. ST segment elevation of myocardial infarction (STEMI) is one category of ACS which occurs when major coronary arteries are fully blocked acutely and diminish coronary...
Saved in:
Main Author: | Ryan Ranitya |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2025-04-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | http://www.actamedindones.org/index.php/ijim/article/view/3016 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME
by: R. G. Oganov, et al.
Published: (2015-12-01) -
Morphofunctional changes and mechanisms of their realization in developing lungs under influence of paracetamol and nimesulid
by: Kharchenko S.V., et al.
Published: (2012-01-01) -
Role of biomarkers of myocardial injury and inflammation in predicting ischemia-reperfusion injury in patients with ST-segment elevation acute coronary syndrome undergoing endovascular revascularization
by: T. V. Rusak, et al.
Published: (2021-12-01) -
Differential diagnosis of acute myocardial injury: a case report and discussion
by: S. A. Boldueva, et al.
Published: (2020-12-01) -
Risk assessment of contrast-induced acute kidney injury in patients with acute myocardial infarction after coronary angiography and percutaneous coronary intervention
by: A. A. Ursta, et al.
Published: (2021-09-01)